IRIS
VISCIDO, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.807
EU - Europa 4.229
AS - Asia 4.216
SA - Sud America 585
Continente sconosciuto - Info sul continente non disponibili 248
AF - Africa 51
OC - Oceania 9
Totale 19.145
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.621
SG - Singapore 1.848
RU - Federazione Russa 1.003
IE - Irlanda 982
CN - Cina 872
BR - Brasile 486
DE - Germania 465
IT - Italia 445
HK - Hong Kong 431
TR - Turchia 400
VN - Vietnam 356
GB - Regno Unito 261
SE - Svezia 255
UA - Ucraina 227
FR - Francia 188
FI - Finlandia 180
CA - Canada 108
IN - India 69
BD - Bangladesh 52
AR - Argentina 44
CZ - Repubblica Ceca 44
JP - Giappone 44
MX - Messico 37
NL - Olanda 35
BE - Belgio 32
PL - Polonia 32
ID - Indonesia 26
ES - Italia 24
IQ - Iraq 22
ZA - Sudafrica 21
CO - Colombia 15
AT - Austria 12
PH - Filippine 12
LT - Lituania 11
VE - Venezuela 10
EC - Ecuador 9
MA - Marocco 8
SA - Arabia Saudita 8
JM - Giamaica 7
KR - Corea 7
MY - Malesia 7
PE - Perù 7
RO - Romania 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CR - Costa Rica 6
JO - Giordania 6
BG - Bulgaria 5
CL - Cile 5
IL - Israele 5
PK - Pakistan 5
TH - Thailandia 5
CH - Svizzera 4
EU - Europa 4
HN - Honduras 4
LB - Libano 4
NI - Nicaragua 4
PT - Portogallo 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BS - Bahamas 3
EG - Egitto 3
GE - Georgia 3
GT - Guatemala 3
NP - Nepal 3
PR - Porto Rico 3
PY - Paraguay 3
AM - Armenia 2
BM - Bermuda 2
CD - Congo 2
CG - Congo 2
GY - Guiana 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
VG - Isole Vergini Britanniche 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
IR - Iran 1
KH - Cambogia 1
Totale 18.889
Salva come PNG Salva come JPEG
Città #
Singapore 1.000
Chandler 979
Dublin 972
Jacksonville 943
Dallas 884
San Jose 859
Ashburn 833
Hong Kong 426
Santa Clara 421
Council Bluffs 340
Boardman 321
New York 230
The Dalles 225
Izmir 197
Nanjing 159
Beijing 158
San Mateo 151
Princeton 150
Lawrence 149
Wilmington 143
Moscow 140
Los Angeles 139
Ho Chi Minh City 121
Ann Arbor 114
Munich 101
Hanoi 79
Lauterbourg 78
Dearborn 76
São Paulo 72
Milan 71
L'aquila 62
Bremen 50
Montreal 48
Hefei 46
Helsinki 42
Seattle 42
Woodbridge 42
Orem 41
Columbus 40
Des Moines 39
Phoenix 39
Rome 39
Brno 38
Nanchang 37
Shenyang 37
Frankfurt am Main 36
London 36
Tokyo 35
Turku 33
Brussels 32
Tianjin 32
Verona 32
Atlanta 31
Kunming 31
San Francisco 31
Warsaw 30
Shanghai 29
Berlin 28
Brooklyn 26
Norwalk 26
Toronto 26
Boston 25
Denver 25
Jinan 25
Lappeenranta 22
Poplar 22
Chennai 21
Amsterdam 20
Stockholm 20
Chicago 19
Mumbai 19
Rio de Janeiro 19
Jiaxing 18
Zhengzhou 18
Haiphong 16
Hebei 16
L’Aquila 16
Belo Horizonte 15
Falkenstein 15
Mexico City 15
Brasília 14
Manchester 14
Pescara 14
Buffalo 13
Houston 13
Mountain View 13
Changsha 12
Dong Ket 12
Fairfield 11
Memphis 11
Ankara 10
Biên Hòa 10
Florence 10
Jakarta 10
Johannesburg 10
Ningbo 10
Da Nang 9
Fremont 9
Guangzhou 9
Hangzhou 9
Totale 12.256
Salva come PNG Salva come JPEG
Nome #
Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case–control and cohort studies 627
Efficacia di un nuovo preparato di olio di pesce sulla recidiva del Morbo di Crohn. Giornale di Gastroenterologia 1996;1:158-162 337
Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients: Systematic Review With Meta-Analysis 311
Serum transglutaminase antibodies do not always detect the persistent villous atrophy in patients with celiac disease on a gluten-free diet 291
Persistent iron deficiency anemia in patients with celiac disease despite a gluten-free diet 257
The Relationship Between Nutritional Status, Micronutrient Deficiency, and Disease Activity in IBD Patients: A Multicenter Cross-Sectional Study 255
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 186
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 179
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 170
Histological healing in ulcerative colitis with mesalazine and its prognostic role 162
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 159
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet 158
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 156
Association between colonic diverticula and colorectal polyps and cancer 151
Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn's Disease: Do They Still Have a Potential Clinical Role? 150
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 149
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 149
Risk of colonoscopic post-polypectomy bleeding in patients on single antiplatelet therapy: systematic review with meta-analysis 148
Association between colorectal polyps and colonic diverticulosis 147
GI distension in severe ulcerative colitis 146
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 146
Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen. 143
Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC) 139
Pericarditis after sars‐cov‐2 infection: Another pebble in the mosaic of long covid? 138
Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease? 136
Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases 136
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 135
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? 134
SpA plus IBD or IBD plus SpA: Does commutative property apply? 132
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. 131
Inflammatory bowel disease: New insights into the interplay between environmental factors and pparγ 131
Are volatile organic compounds accurate markers in the assessment of colorectal cancer and inflammatory bowel diseases? A review 131
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 131
The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patients 130
Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis 130
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 129
Site and duration of abdominal pain discriminate symptomatic uncomplicated diverticular disease from previous diverticulitis patients 126
Colite acuta dopo colonscopia. Giornale di Gastroenterologia 1997; 2: 88-93 126
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy. 126
The usefulness of serum vitamin D levels in the assessment of IBD activity and response to biologics 126
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 123
Mucosal healing: Mayo 0 vs 1 after 3 years. 123
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 123
Magnetic resonance enterography (MRE) and ultrasonography (US) in the study of the small bowel in Crohn's disease: state of the art and review of the literature 123
Celiac disease, gluten-free diet, and metabolic and liver disorders 123
Is mesalazine treatment effective in the prevention of diverticulitis? A review 123
Duodenal lymphocytosis in functional dyspepsia 122
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 122
Association of colonic diverticula with colorectal adenomas and cancer 122
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 122
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nation-wide study. 121
Current management of severe ulcerative colitis. 121
Inflammatory Bowel Disease in the Post-STRIDE II Era: Epidemiology and Long-Term Clinical Outcomes from a Population-Based Study 119
Persistence of anemia in patients with Celiac disease despite a gluten free diet: a retrospective study 119
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. 119
Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis 119
Immunoglobulin G4-Related Disease of the Intestine: A Clinicopathological Entity to Be Considered 118
Nanotechnology in the treatment of inflammatory bowel diseases. 117
Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications 117
Acute colitis following colonoscopy 116
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares 115
5-ASA enemas increase mucosal availability of mesalamine up to splenic flexure. 115
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 115
MRI EVALUATION OF CROHN DISEASE OF THE SMALL AND LARGE BOWEL USING NEGATIVE SUPERPARAMAGNETIC CONTRAST AGENT 113
Prognostic factors for post-operative recurrence of Crohn's disease 113
L’intestino nei pazienti critici. La barriera mucosa intestinale e le sue alterazioni (prima parte). Giornale di Gastroenterologia 1998; 3: 70-103 113
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 112
In favour of prophylactic treatment for post-operative recurrence in Crohn's disease. 112
Dietary factors modulating colorectal carcinogenesis 112
NK activity and antibody-dependent cellular citotoxicity (ADCC) in inflammatory bowel disease(IBD) 111
Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment 111
Safe use of infliximab for the treatment of fistulizing Crohn’s disease during pregnancy within 3 months of conception. 111
The role on endoscopy in alcohol-related diseases 109
The long-term effect on surgery-free survival of biological compared to conventional therapy in Crohn's disease in real world-data: a retrospective study 109
Attività NK ed ADCC in pazienti con malattie infiammatorie intestinali (IBD). 108
Small intestine contrast ultrasonography: An alternative to radiology in the assessment of small bowel disease 107
Colonic mucosal concentration of 5-ASA in ulcerative colitis. 106
Acute colitis following endoscopy: an outbreak of three cases 106
Unmet medical needs in the management of ulcerative colitis: Results of an Italian delphi consensus 106
Italian Group for the Study of the Colon and Rectum: Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study 105
Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. 104
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 104
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 103
Quinidine-induced colitis. Report of three cases. 103
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis. 103
A new technique of magnetic resonance imaging (MRI) in the management of patients with Crohn's disease. 102
An unusual treatment for a colonic polyp. 101
Value of T2-weighted fat suppressed and non suppressed sequences after oral administration of a superparamagnetic contrast agent in the assessmento of Crohn's disease activity 101
Recidive stenosanti ricorrenti nel morbo di Crohn. Giornale di Gastroenterologia, 1999, 4: 150-155 101
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations 100
Evaluation of Crohn disease activity with magnetic resonance imaging 100
Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist. 99
Linfociti circolanti gamma-delta in corso di malattie infiammatorie intestinali. 99
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 98
Two mesalazine regimens in the prevention of postoperative recurrence of Crohn's disease: A double blind randomised clinical trial. AGISC study. 98
5-ASA enemas increase mucosal availability of mesalamine up to splenic flexure. 98
Gastrointestinal distension in severe ulcerative colitis 97
Il 5-ASA (ASACOL) previene le recidive post-operatorie del morbo di crohn (MC): risultati dello studio GISC a tre anni di follow-up. 97
Wegener's granulomatosis and retroperitoneal fibrosis: A case report and review of the literature 97
Two mesalazine regimens in the prevention of postoperative recurrence of Crohn's disease: A pragmatic double blind randomised controlled trial . Aliment Pharmacol Ther 2003;17:517-523 97
Totale 13.567
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022705 0 0 94 39 32 27 12 58 43 32 68 300
2022/20232.841 216 159 44 293 257 301 0 204 1.233 16 84 34
2023/2024990 98 28 29 91 47 167 30 285 4 39 51 121
2024/20253.074 69 50 288 98 298 317 382 265 686 180 222 219
2025/20266.496 253 640 602 759 627 452 1.021 217 582 816 429 98
2026/20271.406 719 543 144 0 0 0 0 0 0 0 0 0
Totale 19.145